Aussie Cannabis stocks surge while the virus wreaks havoc on the rest of the market

Boy wasn’t the ASX a bumpy ride this week. The market started strong with Monday and Tuesday showing signs of a recovery. However, the comeback was short-lived as Wednesday and Friday continued the bearish trend.   After closing 2.81% lower for the week it seems the Coronavirus fear is not going away anytime soon. Especially […]

Will 2020 drive Cannabis growth or continue the bearish trend?

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. The cannabis industry evokes both unprecedented excitement and frustration in investors. Let me take you through the cannabis story. We first flashback to 2017 and 2018 where the industry was […]

Why this ASX cannabis stock is the only one worth watching in 2020?

Every cannabis stock has its story. Ecofibre (ASX: EOF) experienced an 88% YTD increase since listing at $1.70 back in March 2019. Unlike, your traditional cannabis company EOF operates under a unique business model. EOF’s cannabis footprint covers medicinal cannabis, plant-based protein and HEMP. EOF strives to use cannabis to change people’s lives. First, by […]

Is the highest ASX cannabis performer worth the investment during 2020?

Over 2019 Cann Group Ltd (ASX: CAN) plummeted by 82% . In turn, investors sold their shares and CAN appeared to be another speculative cannabis stock. However, CAN surged by 177% in the first three weeks of 2020. Consequently, CAN’s impressive increase makes it the best ASX cannabis stock performer in 2020*. Why has CAN […]

After a 65% decrease is this stock a perfect buy for 2020?

Botanix Pharmaceuticals (ASX: BOT) is an Australian medicinal cannabis company. Botanix focuses on delivering treatments to fight serious skin diseases. These include acne, psoriasis, and atopic dermatitis. Botanix looks to disrupt the skincare market by harnessing the potential of cannabidiol. Existing skincare treatments produce unpleasant side effects. Thus, providing Botanix, if their novel drugs are […]

ASX cannabis stock plunges 90%, could this opportunity allow investors to enter the cannabis market for 2020?

ASX cannabis stocks are speculative. Australia has no clear cannabis leader. Because of the bearish storm that brought most of the industry down in 2019. Today we analyse whether Creso Pharma’s decrease provides market entry for investors? Creso Pharma (CPH) is an Australian cannabis company with operations in Israel, Australia, Colombia, Canada, and Switzerland. CPH […]

Bearish trend sees cannabis stocks plummet, how will the industry cope in 2020?

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Flashback to 2018 and the cannabis industry was booming with uncontrollable excitement. Penny stocks were surging to record highs. Primarily, because Investors saw the cannabis market as a megatrend with […]

Cannabis market plummets BUT could Ecofibre, after surging 103%, be the holy grail for 2020?

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. The cannabis market is speculative. No doubt about it. You would have heard investors say, “cannabis stocks are too risky, most of them are unprofitable, and promise extraordinary growth”. For […]

Is it worth shutting the gate on CAN after their 60% plummet?

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. CAN The Australian medicinal cannabis market is speculative, volatile, and dependent on the anticipated growth in demand. Cann Group Limited’s recent plummet captures the current market conditions perfectly. The key […]

ECS Botanics surges by 46%, is time running out to buy into this emerging HEMP winner?

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Yesterday ECS Botanics Holdings Ltd surged by 46.6%. But why? Before we answer this all-important cannabis investment question, you must understand the background of ECS Botanics first. ECS is a […]

Cann Group losing value as bearish market trend sets in – How much more will investors take?

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Introduction Cann Group (CAN) Cann Group (CAN) is an Australian medicinal cannabis company. Cann aims to research, cultivate, and manufacture a range for medicinal cannabis products for patients in Australia […]

2019 EXL stock plummet – perfect time to break into cannabis market ?

Introduction into Hemp Market Hemp. The word in the cannabis market that instantly grabs our attention. So, what is Hemp? Hemp is from the Cannabis Sativa plant. Sativa contains Tetrahydrocannabinol (THC). THC at high concentrations has profound narcotic effects. However, Sativa with low THC (<0.3%) is deemed harmless and is legal to cultivate. The useable […]

AusCann holds major potential in Australian medicinal market?

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. Short Intro on medicinal cannabis Medicinal cannabis, unlike HEMP and recreational, already has the legislative framework for pharmaceutical companies to prescribe to patients. Medicinal cannabis (CBD) is from both the […]

Worldwide Cannabis market provides promising investment opportunities

Before I start, I am obliged to remind our viewers that this is not advice only general commentary from my extensive research in this area. When you hear the word cannabis, you might think of a criminalised drug that allows you to get high. However, in recent decades legalised cannabis is being viewed as a […]